Literature DB >> 20376717

Interplay of host and infectious agents.

Eman Abou Ouf1, Silke Bechlars, Evelyn Böttger, Birgül Büyükyazici, Imad Faik, Elisandra Grangeiro de Carvalho, Stefanie Meese, Azzaya Oktyabri, Oluyinka Ol Opaleye, Velavan T P, Jürgen F J Kun.   

Abstract

In this group we would like to answer the question why people show a different response against certain pathogens. In many infections the course of the disease can range from asymptomatic carriage to the severest forms even death. In the past we have analysed candidate genes and their role in the course of malaria and could detect some polymorphisms influencing infectious diseases in the genes encoding NOS2, MBL2, IFNa, FCN2, and receptors for IFNg and IFNa. Having worked initially mainly on malaria we broadened our spectrum also to other infectious diseases like hepatitis B, Leprosy, schistosomiasis. Here we give a short overview about ongoing projects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376717     DOI: 10.1007/s00508-010-1328-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  24 in total

1.  Deficiency for mannan-binding lectin is associated with antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their relatives.

Authors:  F Seibold; A B W Boldt; B Seibold-Schmid; A M Schoepfer; B Flogerzi; S Müller; J F J Kun
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 2.  Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis.

Authors:  D L Jack; N J Klein; M W Turner
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

3.  A promoter polymorphism in the interferon alpha-2 gene is associated with the clinical presentation of hepatitis B.

Authors:  Le H Song; Nguyen L Toan; Nguyen T Xuan; Anne-Catrin Uhlemann; Angelica B W Boldt; Dinh N Duy; Vu Q Binh; Peter G Kremsner; Jürgen F J Kun
Journal:  Mutat Res       Date:  2006-08-21       Impact factor: 2.433

4.  Dual role of mannan-binding protein in infections: another case of heterosis?

Authors:  P Garred; M Harboe; T Oettinger; C Koch; A Svejgaard
Journal:  Eur J Immunogenet       Date:  1994-04

5.  The mannan-binding lectin (MBL) pathway of complement activation: biochemistry, biology and clinical implications.

Authors:  Jens Christian Jensenius
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

6.  Recognition of plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system.

Authors:  Jens Klabunde; Anne-Catrin Uhlemann; Anne E Tebo; Jürgen Kimmel; Ralph T Schwarz; Peter G Kremsner; Jürgen F J Kun
Journal:  Parasitol Res       Date:  2002-02       Impact factor: 2.289

7.  Analysis of polymorphic sites in the promoter of the nitric oxide synthase 2 gene.

Authors:  Valentina Coia; Simone Jüliger; Benjamin Mordmüller; Andrea Kreidenweis; Anna-Lena Stroh; Claudia Ortega; Alessandro Vindigni; Jörn Dengjel; Dmitry V Lukyanov; Giovanni Destro-Bisol; Anton Fedorov; Olga I Podgornaya; Jürgen F J Kun
Journal:  Biochem Biophys Res Commun       Date:  2005-10-07       Impact factor: 3.575

8.  Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study.

Authors:  Frank Seibold; Angelica B W Boldt; Beatrice Seibold-Schmid; Alain M Schoepfer; Beatrice Flogerzi; Stefan Müller; Jürgen F J Kun
Journal:  Inflamm Bowel Dis       Date:  2007-09       Impact factor: 5.325

9.  Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I.

Authors:  Simone Jüliger; Martina Bongartz; Adrian J F Luty; Peter G Kremsner; Jürgen F J Kun
Journal:  Immunogenetics       Date:  2002-12-14       Impact factor: 2.846

10.  Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients.

Authors:  Le H Song; Vu Q Binh; Dinh N Duy; Simone Jüliger; Thomas C Bock; Adrian J F Luty; Peter G Kremsner; Jürgen F J Kun
Journal:  Mutat Res       Date:  2003-01-28       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.